全文获取类型
收费全文 | 70673篇 |
免费 | 5185篇 |
国内免费 | 2054篇 |
专业分类
耳鼻咽喉 | 447篇 |
儿科学 | 1163篇 |
妇产科学 | 1023篇 |
基础医学 | 5482篇 |
口腔科学 | 825篇 |
临床医学 | 8774篇 |
内科学 | 16162篇 |
皮肤病学 | 192篇 |
神经病学 | 4318篇 |
特种医学 | 5595篇 |
外国民族医学 | 8篇 |
外科学 | 11662篇 |
综合类 | 11068篇 |
现状与发展 | 6篇 |
预防医学 | 2787篇 |
眼科学 | 885篇 |
药学 | 4330篇 |
26篇 | |
中国医学 | 1700篇 |
肿瘤学 | 1459篇 |
出版年
2024年 | 49篇 |
2023年 | 963篇 |
2022年 | 1448篇 |
2021年 | 2594篇 |
2020年 | 2473篇 |
2019年 | 2301篇 |
2018年 | 2321篇 |
2017年 | 2025篇 |
2016年 | 2052篇 |
2015年 | 2258篇 |
2014年 | 4665篇 |
2013年 | 4653篇 |
2012年 | 3906篇 |
2011年 | 4368篇 |
2010年 | 3700篇 |
2009年 | 3802篇 |
2008年 | 3923篇 |
2007年 | 3968篇 |
2006年 | 3652篇 |
2005年 | 3188篇 |
2004年 | 2600篇 |
2003年 | 2244篇 |
2002年 | 1871篇 |
2001年 | 1743篇 |
2000年 | 1385篇 |
1999年 | 1176篇 |
1998年 | 1046篇 |
1997年 | 983篇 |
1996年 | 756篇 |
1995年 | 797篇 |
1994年 | 647篇 |
1993年 | 587篇 |
1992年 | 537篇 |
1991年 | 422篇 |
1990年 | 359篇 |
1989年 | 290篇 |
1988年 | 289篇 |
1987年 | 250篇 |
1986年 | 198篇 |
1985年 | 268篇 |
1984年 | 225篇 |
1983年 | 146篇 |
1982年 | 177篇 |
1981年 | 146篇 |
1980年 | 123篇 |
1979年 | 97篇 |
1978年 | 78篇 |
1977年 | 56篇 |
1976年 | 44篇 |
1975年 | 20篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
31.
Sumit Arora Jatin Talwar Vikramadittya Singh Vikas Gupta 《Indian Journal of Thoracic and Cardiovascular Surgery》2021,37(3):307
Tuberculosis in the tibial diaphysis following saphenous vein graft harvest for coronary artery bypass grafting has not been reported, to the best of authors’ knowledge. We report the first such clinical case in view of its clinical rarity and as a complication of the simple procedure like saphenous vein graft harvest. 相似文献
32.
《Journal of Cardiovascular Computed Tomography》2021,15(6):492-498
BackgroundCompared with invasive fractional flow reserve (FFR), coronary CT angiography (cCTA) is limited in detecting hemodynamically relevant lesions. cCTA-based FFR (CT-FFR) is an approach to overcome this insufficiency by use of computational fluid dynamics. Applying recent innovations in computer science, a machine learning (ML) method for CT-FFR derivation was introduced and showed improved diagnostic performance compared to cCTA alone. We sought to investigate the influence of stenosis location in the coronary artery system on the performance of ML-CT-FFR in a large, multicenter cohort.MethodsThree hundred and thirty patients (75.2% male, median age 63 years) with 502 coronary artery stenoses were included in this substudy of the MACHINE (Machine Learning Based CT Angiography Derived FFR: A Multi-Center Registry) registry. Correlation of ML-CT-FFR with the invasive reference standard FFR was assessed and pooled diagnostic performance of ML-CT-FFR and cCTA was determined separately for the following stenosis locations: RCA, LAD, LCX, proximal, middle, and distal vessel segments.ResultsML-CT-FFR correlated well with invasive FFR across the different stenosis locations. Per-lesion analysis revealed improved diagnostic accuracy of ML-CT-FFR compared with conventional cCTA for stenoses in the RCA (71.8% [95% confidence interval, 63.0%–79.5%] vs. 54.8% [45.7%–63.8%]), LAD (79.3 [73.9–84.0] vs. 59.6 [53.5–65.6]), LCX (84.1 [76.0–90.3] vs. 63.7 [54.1–72.6]), proximal (81.5 [74.6–87.1] vs. 63.8 [55.9–71.2]), middle (81.2 [75.7–85.9] vs. 59.4 [53.0–65.6]) and distal stenosis location (67.4 [57.0–76.6] vs. 51.6 [41.1–62.0]).ConclusionIn a multicenter cohort with high disease prevalence, ML-CT-FFR offered improved diagnostic performance over cCTA for detecting hemodynamically relevant stenoses regardless of their location. 相似文献
33.
《Vaccine》2021,39(45):6601-6613
AKS-452 is a biologically-engineered vaccine comprising an Fc fusion protein of the SARS-CoV-2 viral spike protein receptor binding domain antigen (Ag) and human IgG1 Fc (SP/RBD-Fc) in clinical development for the induction and augmentation of neutralizing IgG titers against SARS-CoV-2 viral infection to address the COVID-19 pandemic. The Fc moiety is designed to enhance immunogenicity by increasing uptake via Fc-receptors (FcγR) on Ag-presenting cells (APCs) and prolonging exposure due to neonatal Fc receptor (FcRn) recycling. AKS-452 induced approximately 20-fold greater neutralizing IgG titers in mice relative to those induced by SP/RBD without the Fc moiety and induced comparable long-term neutralizing titers with a single dose vs. two doses. To further enhance immunogenicity, AKS-452 was evaluated in formulations containing a panel of adjuvants in which the water-in-oil adjuvant, Montanide™ ISA 720, enhanced neutralizing IgG titers by approximately 7-fold after one and two doses in mice, including the neutralization of live SARS-CoV-2 virus infection of VERO-E6 cells. Furthermore, ISA 720-adjuvanted AKS-452 was immunogenic in rabbits and non-human primates (NHPs) and protected from infection and clinical symptoms with live SARS-CoV-2 virus in NHPs (USA-WA1/2020 viral strain) and the K18 human ACE2-trangenic (K18-huACE2-Tg) mouse (South African B.1.351 viral variant). These preclinical studies support the initiation of Phase I clinical studies with adjuvanted AKS-452 with the expectation that this room-temperature stable, Fc-fusion subunit vaccine can be rapidly and inexpensively manufactured to provide billions of doses per year especially in regions where the cold-chain is difficult to maintain. 相似文献
34.
Shylo R. Johnson Dennis Slate Kathleen M. Nelson Amy J. Davis Samual A. Mills John T. Forbes Kurt C. VerCauteren Amy T. Gilbert Richard B. Chipman 《Viruses》2021,13(2)
Since the 1990s, oral rabies vaccination (ORV) has been used successfully to halt the westward spread of the raccoon rabies virus (RV) variant from the eastern continental USA. Elimination of raccoon RV from the eastern USA has proven challenging across targeted raccoon (Procyon lotor) and striped skunk (Mephitis mephitis) populations impacted by raccoon RV. Field trial evaluations of the Ontario Rabies Vaccine Bait (ONRAB) were initiated to expand ORV products available to meet the rabies management goal of raccoon RV elimination. This study describes the continuation of a 2011 trial in West Virginia. Our objective was to evaluate raccoon and skunk response to ORV occurring in West Virginia for an additional two years (2012–2013) at 75 baits/km2 followed by three years (2014–2016) of evaluation at 300 baits/km2. We measured the change in rabies virus-neutralizing antibody (RVNA) seroprevalence in targeted wildlife populations by comparing levels pre- and post-ORV during each year of study. The increase in bait density from 75/km2 to 300/km2 corresponded to an increase in average post-ORV seroprevalence for raccoon and skunk populations. Raccoon population RVNA levels increased from 53% (300/565, 95% CI: 50–57%) to 82.0% (596/727, 95% CI: 79–85%) during this study, and skunk population RVNA levels increased from 11% (8/72, 95% CI: 6–20%) to 39% (51/130, 95% CI: 31–48%). The RVNA seroprevalence pre-ORV demonstrated an increasing trend across study years for both bait densities and species, indicating that multiple years of ORV may be necessary to achieve and maintain RVNA seroprevalence in target wildlife populations for the control and elimination of raccoon RV in the eastern USA. 相似文献
35.
36.
Florent Le Ven François Pontana Gilles Barone-Rochette Laurent Macron Jérome Garot Olivier Genée Damien Mandry Luc Christiaens Alain Furber Jean Nicolas Dacher Alexis Jacquier 《Diagnostic and interventional imaging》2021,102(6):337-345
This position paper was intended to update the former consensus between the French Societies of Radiology and Cardiology about the use of stress cardiac magnetic resonance imaging (MRI) in chronic coronary syndrome published in 2009. The Delphi method was used to build the present consensus. This expert panel consensus includes recommendations for indications, procedure with patient preparation, stress inducing drugs, acquisition protocol, interpretation and risk stratification by stress MRI. 相似文献
37.
38.
《Indian heart journal》2022,74(1):1-6
Familial hypercholesterolemia (FH) is a common autosomal dominant disorder that affects ~1 in 250–500 individuals globally. The only prevalence study in India shows FH in 15% of patients with premature CAD in North Indians. There are only 6 genetic studies in India of the total mutations, 32% are LDLR mutations, 4% are ApoB, 2% are PCSK9 mutations and the mutational spectrum for 37% is unknown. This calls for widespread genetic screening which could help identify definite FH patients.European Atherosclerosis Society-Familial Hypercholesterolemia Studies Collaboration (EAS- FHSC) has taken an initiative to develop a worldwide registry of FH. India is also a part of the collaboration and 3 groups from Mumbai, Delhi and Chennai are actively contributing to this registry. We believe this review might help to understand the Indian scenario of FH and investigators across India can contribute in managing FH in India and further help in the detection, diagnosis and treatment. 相似文献
39.
40.
学者们对动脉血管的研究常聚焦在血管内膜动脉粥样硬化(As)斑块的形成,而很少关注血管外膜的免疫反应及其对疾病病程的影响。前期研究发现,老龄的ApoE-/-小鼠动脉外膜出现免疫细胞的有序集聚,形成类似淋巴结的异位淋巴组织,称之为动脉三级淋巴组织(ATLO),其形成对内膜As具有明显的调控作用。ATLO的发现及研究为As的研究指明了新的方向,并为其他疾病状况下三级淋巴组织(TLO)的研究提供了很好的范例。因此,阐明TLO的特点及形成机制对As的防治具有重要的意义,并为其在其他疾病中的临床运用提供坚实的基础。 相似文献